Elena Cantone

Medical University of Vienna — Austria

Neuroscience · Life Sciences

27h-index2.6kcitations156works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Olfactory and Sensory Function Studies(34), Sinusitis and nasal conditions(34), Allergic Rhinitis and Sensitization(29), Biochemical Analysis and Sensing Techniques(23), Nasal Surgery and Airway Studies(21)

Publications155 total

A network-based approach to assess task-compliance in fMRI
Epilepsy & Behavior·2026
A patient-centric approach to chronic rhinosinusitis with nasal polyps (CRSwNP): developing tools to improve disease management and outcomes
European Archives of Oto-Rhino-Laryngology·2025Open Access
Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis
Journal of the Neurological Sciences·2025· 2 citedOpen Access
Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the <scp>DUPIREAL</scp> Population
Clinical Otolaryngology·2025
Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events
The Journal of Allergy and Clinical Immunology In Practice·2025
Peak nasal inspiratory flow as an adjunct measure of respiratory function in paediatric cystic fibrosis
Journal of Cystic Fibrosis·2025
The Overlooked Burden of Atopic Comorbidities in Eosinophilic Esophagitis: Insights from a Real-Life Comprehensive Multidisciplinary Evaluation
Journal of Clinical Medicine·2025Open Access
Optimising care for chronic rhinosinusitis with nasal polyps and asthma in multimorbid patients: a multidisciplinary Delphi consensus
Acta Otorhinolaryngologica Italica·2025Open Access
Two‐Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
Allergy·2025· 4 cited
Post-vaccination chemosensory outcomes in COVID-19-associated dysfunction
2025Open Access
OC.07.3 LONG-TERM DUPILUMAB TREATMENT IMPROVES EATING BEHAVIOURS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
Digestive and Liver Disease·2025
Erectile dysfunction and obstructive sleep apnea syndrome: a post-hoc evaluation of Italian survey results
Minerva Urology and Nephrology·2025
Proposal of a New Composite Score (DAMADECO) to Simultaneously Evaluate Asthma and CRSwNP Severity in Comorbid Patients
Journal of Clinical Medicine·2025Open Access
The Potential Role of Nasal Cytology in Respiratory Diseases: Clinical Research and Future Perspectives
Journal of Clinical Medicine·2025· 3 citedOpen Access
TAS2R38 genotype and CRS severity in children with cystic fibrosis
Heliyon·2025· 3 citedOpen Access
The Effects of Mepolizumab on CRSwNP: Real-Life Evidence
Journal of Personalized Medicine·2024· 4 citedOpen Access
In Reference to <i>Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps</i>
The Laryngoscope·2024
T.01.1: INCREASED PREVALENCE OF DYSPHAGIA IN PATIENTS WITH SEVERE ATOPIC DERMATITIS CANDIDATES TO BIOLOGICAL THERAPY: IMPLICATIONS FOR DIAGNOSIS AND MANAGEMENT OF TH2-RELATED DISORDERS
Digestive and Liver Disease·2024
T.09.2: EOSINOPHILIC ESOPHAGITIS AND TH2 COMORBIDITIES: ANALYSIS OF PREVALENCE AND NEED FOR A MULTIDISCIPLINARY TEAM APPROACH
Digestive and Liver Disease·2024
Multidimensional Impact of Dupilumab on Chronic Rhinosinusitis with Nasal Polyps: A Complete Health Technology Assessment of Clinical, Economic, and Non-Clinical Domains
Journal of Personalized Medicine·2024· 1 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Maurizio Iengo(15), Eugenio De Corso(13), Giancarlo Ottaviano(11), Veronica Seccia(7), Daniela Lucidi(7), Gaetano Paludetti(7), Jacopo Galli(7), Gaetano Motta(6), Francesco Di Salle(6), Andrea Ciofalo(5), Stefano Settimi(5), Fabrizio Esposito(5), Anna Prinster(5), Antonella Miriam Di Lullo(5), Maria Paola Cecchini(4), Ignazio La Mantia(4), Tiziana Di Cesare(4), Annamaria Colao(3), Kathrin Ohla(3), Paule V. Joseph(3)